Co-Founder

Regulatory actions for Sept. 23, 2025

Bunkerhill Secures FDA Clearance for ECG-EF, Using AI to Detect Reduced Ejection Fraction from Routine ECGs

Bunkerhill Health Achieves FDA Clearance for Opportunistic Bone Density Assessment on Routine Abdominal CT

Other news to note for March 4, 2025

Sales Development Representative

Bunkerhill Health provides a way for researchers to activate their AI algorithms for clinical use, and they are seeking a Sales Development Representative (SDR) to drive revenue growth. The SDR will initiate and nurture relationships with healthcare executives, focusing on proactive outbound prospecting to generate leads.

Sign up with Google

Sign in with Google